Markets
markets
Jon Keegan

AT&T beats on revenue, adds more wireless and fiber customers, will see big savings from tax bill

AT&T posted solid second-quarter earnings, beating estimates, and plans to use $6.5 billion to $8 billion in tax savings from President Trump’s tax bill to build out its fiber business. However, the stock is slumping in premarket trading, as the company’s full-year profit guidance failed to impress.

The company posted $30.8 billion in revenue, up 3.5% year on year, beating estimates of $30.4 billion on higher wireless and consumer sales. Adjusted earnings per share came in at $0.54, beating FactSet analysts’ expectations of $0.53.

Net income for Q2 was $4.9 billion, up from $3.9 billion from the same period in the year prior.

The company saw 401,000 postpaid phone net additions (new monthly subscriptions, minus lost customers) for the quarter.

Mobility service revenue was $16.9 billion, up 3.5% year on year, while consumer fiber broadband revenues were up 18.9% from Q2 2024 to $2.1 billion. The company added 243,000 new fiber subscribers.

AT&T Chairman and CEO John Stankey said in the earnings release:

“We are winning in a highly competitive marketplace, with the nation’s largest wireless and fiber networks.”

Guidance for the full year calls for adjusted earnings per share of between $1.97 and $2.07, and capital expenditures between $22 billion and $25 billion. That profit estimate may be the fly in the ointment here: even the high end of that range is below the consensus estimate of $2.09, per analysts polled by Bloomberg.

The company also said it’s expecting “low double-digit” declines in business wireless EBITDA.

The company said it expects to see $6.5 billion to $8 billion of cash tax savings between 2025 and 2027, thanks to Trump’s tax bill that was just signed into law. Of those savings, $3.5 billion will go into accelerating its fiber internet network, and the company expects to reach 60 million fiber customers when including the Lumen Technologies customers it agreed to acquire.

More Markets

See all Markets
markets

Bullish options flows boost Rivian

EV maker Rivian is up nearly 5% on Monday afternoon as bullish options flows lift the stock ahead of its third-quarter earnings, set to drop next week.

According to Bloomberg, Rivian call options traded outnumber put options more than five to one, for a put/call ratio of less than 0.2 as of 2:38 p.m. ET. That’s significantly less than the 20-day put/call average of 0.4. More than 116,000 call options have changed hands, more than 60% above the full-day average over the past 20 days.

Rivian’s upcoming earnings will measure the automaker’s sales ahead of the expiration of the $7,500 EV tax credit. Since September, Rivian has performed two rounds of layoffs as it seeks to cut costs amid the end of regulatory credits and ahead of next year’s lower-cost SUV launch.

markets

Palantir inks defense deal with Poland, touches new intraday high

Palantir Technologies touched a new intraday high of $192.83 early Monday, as the company rode the China trade truce rally in AI tech stocks and retail favorites.

Palantir also signed a new deal to supply the government of Poland with data, AI, and cybersecurity software, according to Bloomberg.

Polish Minister of Defense Wladyslaw Kosiniak-Kamysz and Palantir CEO Alex Karp signed the letter of intent on the deal, about which few details were released. Polish officials did signal that they were interested in Palantir software systems for “battlefield management” and logistics. Up more than 150% this year, Palantir reports Q3 earnings on November 3.

Polish Minister of Defense Wladyslaw Kosiniak-Kamysz and Palantir CEO Alex Karp signed the letter of intent on the deal, about which few details were released. Polish officials did signal that they were interested in Palantir software systems for “battlefield management” and logistics. Up more than 150% this year, Palantir reports Q3 earnings on November 3.

markets

Intellia tanks as it pauses late-stage CRISPR gene-editing trials after one patient was hospitalized

Intellia dropped sharply on Monday after it announced that it’s pausing two late-stage CRISPR gene-editing trials because one patient was hospitalized with liver damage.

Intellia had also disclosed in May that a patient had experienced elevated liver enzymes. The news is a major setback for the company, which currently has no products on the market and is working on a one-time treatment for heart and nerve conditions.

The news dragged down other companies working on CRISPR treatments, including Beam Therapeutics Inc, Crispr Therapeutics, Editas Medicine, and Prime Medicine.

markets

Gold craters as retail traders pull money from commodity ETFs

As its fierce rally begins to fade, it looks like retail traders are waving au revoir to gold.

JPMorgan strategist Arun Jain noted that retail traders have pulled about $120 million from commodity ETFs as of 11 a.m. ET on Monday, a level that stands in the 0.4th percentile relative to its one-year average. The SPDR Gold Shares ETF is down 2.8% as of 11:53 a.m. ET after suffering its worst loss since April 2013 last Tuesday. That day, retail had pulled just $50 million from commodity ETFs by 11 a.m.

The five-session average daily flows into the product hit an all-time high of nearly $1.1 billion last Monday as gold and silver had effectively become the new meme stocks, displaying strong momentum and heavy options activity.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.